Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 14 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Early Detection of Cancer 1

Interventions

pembrolizumab 282 Carboplatin 217 Cisplatin 147 Gemcitabine 146 Paclitaxel 142 Bevacizumab 116 Pemetrexed 114 Docetaxel 101 Oxaliplatin 79 durvalumab 78 Dexamethasone 77 Fluorouracil 76 atezolizumab 75 Nivolumab 75 Cyclophosphamide 74 130-nm albumin-bound paclitaxel 71 Fulvestrant 70 Capecitabine 64 Cetuximab 63 Injections 62 Leucovorin 60 Rituximab 55 fludarabine 50 Lenalidomide 50 venetoclax 44 Prednisone 43 Irinotecan 42 Letrozole 40 enzalutamide 39 tislelizumab 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Genetic Testing × 90 days × Clear all

NCT03897374 2026-03-19

STOP-Cancer

ClinLogic LLC

120,000 enrolled

Early Detection of Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡